It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The structures of the Fc base of various IgG antibodies have been examined with a view to understanding how this region can be used to conjugate IgG to nanoparticles. The base structure is found to be largely consistent across a range of species and subtypes, comprising a hydrophobic region surrounded by hydrophilic residues, some of which are charged at physiological conditions. In addition, atomistic Molecular Dynamics simulations were performed to explore how model nanoparticles interact with the base using neutral and negatively charged gold nanoparticles. Both types of nanoparticle interacted readily with the base, leading to an adaptation of the antibody base surface to enhance the interactions. Furthermore, these interactions left the rest of the domain at the base of the Fc region structurally intact. This implies that coupling nanoparticles to the base of an IgG molecule is both feasible and desirable, since it leaves the antibody free to interact with its surroundings so that antigen-binding functionality can be retained. These results will therefore help guide future attempts to develop new nanotechnologies that exploit the unique properties of both antibodies and nanoparticles.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Strathclyde, EPSRC Future Manufacturing Research Hub for Continuous Manufacturing and Advanced Crystallisation, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138); SiMologics Ltd. The Enterprise Hub, Glasgow, UK (GRID:grid.11984.35); University of Strathclyde, Department of Chemical and Process Engineering, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138)
2 University of Strathclyde, Department of Chemical and Process Engineering, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138); University of Strathclyde, Archie-West, Department of Physics, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138)
3 University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138)
4 University of Strathclyde, Department of Chemical and Process Engineering, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138)




